Studies and Reports

Position Papers and Participation in Public Consultation Procedures

2024

Comments from the CEFI Foundation on the draft Royal Decree regulating the advertising of medical devices

2024

The CEFI Foundation expresses its firm opposition to the proposed amendment of Article 26.2 of the Law on the Government, relating to the public consultation procedure, as put forward through Amendment No. 76 submitted by the Socialist Parliamentary Group and the Sumar Parliamentary Group.

2023

Proposals of the CEFI Foundation in response to the prior public consultation on the draft Royal Decree on Health Technology Assessment

2023

Application of the Transparency Law in the Pharmaceutical Sector (2013–2023)

2022

CEFI’s Observations on the Communication Regarding the Criteria for Determining the Prohibition to Contract Due to Distortion of Competition by the Spanish National Commission on Markets and Competition (CNMC)

2021

Why would compulsory licences for COVID-19 vaccines and treatments not lead to better access to innovation or benefits for patients?

2020

CEFI Position Paper: Changes to the National Health System in Favour of Innovation, Efficiency and Patient Care

2019

CEFI Position Paper: Transparency in Medicine Pricing

2019

The Manufacturing Waiver for Export Purposes of the SPC vs. the Protection of Industrial Property and Biomedical Innovation

2019

Transparency in Medicine Pricing: Current Framework and Legal Analysis

2015

Questions and Answers on Biological and Biosimilar Medicines